Exclusion criteria:
|
1.Combined with gastric and duodenal ulcers, see mucosal erosion and blood infiltration under gastroscopy, pathological examination suggests gastric mucosal atrophy, intestinal differentiation or hyperplasia;
2.Hp infection was positive (bacterial culture, histological examination, urea breath test, rapid urease test and fecal resistance , One diagnosis of the original test was positive);
3.Patients with gastroesophageal reflux disease (typical heartburn and reflux symptoms)
4.There are organic lesions of the digestive system (such as chronic pancreatitis, etc.), or systemic diseases that affect the digestive tract dynamics (for example: diabetes, chronic renal dysfunction, connective tissue disease, psychiatric and neurological lesions,etc.);
5.History of gastric / abdominal surgery (except caesarean section, appendectomy)
6.Traditional Chinese and western medicine treatment drugs (such as: gastric motility drugs and antibile) have been used within nearly 2 weeks after this disease Alkalinergic drugs, proton pump inhibitors, H2 receptor antagonists, etc.);
7.With severe primary cardiovascular lesions, liver lesions (ALT> 1.5 times normal, and / or AST> 1.5 times normal), renal lesions, hematological lesions, lung disease, or serious diseases affecting their survival, such as tumor or AIDS;
8.Psychisis and those with intellectual and language disorders;
9.Women during pregnancy or lactation;
10.allergic constitution or allergic to the drug composition of this preparation;
11.Participating in other drug clinical trials in or within 4 weeks;
12.Long-term sedative and hypnotic drugs (medication> 3 times a week), antidepressants, and opiate preparations;
13.Suspected or real history of alcohol or substance abuse; or judged by the researchers to reduce the probability of enrollment Or complicate the group, such as frequent working environment changes, prone to loss of visit.
|